AI Spending Shock Triggers £225bn Software Sell-Off as Big Tech Pledges $650bn
This week's market action represents a brutal repricing of risk, erasing over a trillion dollars from Big Tech valuations alone. The narrative has shifted from AI as a magic margin-booster to a capital-intensive arms race with an uncertain payoff, a reality check that has rippled through software, crypto, and consumer stocks, leaving major indices on track for their worst week in months.
Market Snapshot
- 📈 DOW FUTURES: +0.43%
- 📈 S&P 500 FUTURES: +0.45%
- 📈 NASDAQ 100 FUTURES: +0.56%
- 📉 S&P 500: 6,798 (-1.23%)
- 📉 NASDAQ: 22,541 (-1.59%)
- 📉 DOW: 48,909 (-1.20%)
- 📉 FTSE 100 (U.K.): (-0.90%)
- 📉 STOXX 600 (E.U.): (-1.05%)
- 📉 CSI 300 (CN): (-0.60%)
- 📉 US 10-Year Treasury: 4.184% (-0.6176%)
- 📉 Bitcoin (BTC): ~$60,500 (-29.8% week-on-week)
- 📉 Ethereum (ETH): $1,875 (-12.54%)
Big Tech's $650bn AI Gamble Roils Markets
The technology sector is undergoing a fundamental reset after the industry's four largest players—Amazon, Alphabet, Meta, and Microsoft—collectively forecast approximately $650 billion (£515 billion) in capital expenditures for 2026. This monumental spending programme, directed primarily at building out AI infrastructure, has wiped out more than $1 trillion from their combined market capitalisation this week. The spending is nearly four times the combined planned investment of 21 major industrial giants, including Exxon and Walmart.
This signals a strategic pivot from the 'asset-light' models that once defined Big Tech to a new era of capital-intensive industrialisation. Meta's property and equipment assets, for instance, have already quintupled since 2019, and even after enjoying post-earnings gains, the social media giant has seen its stock give back those advances amid the wider sector rout.
Amazon's Spending Stuns Investors
Amazon sits at the centre of this spending storm, with a staggering $200 billion capex projection for this year alone, a figure that far surpassed analyst expectations. Shares were down more than 8% in pre-market trading as investors grappled with the implications. The prevailing belief that AI would seamlessly boost margins has been replaced by the stark reality of a costly infrastructure war. CEO Andy Jassy remains "confident" in the plan, which could see capital expenditure double by the end of 2027, citing "seminal opportunities" in AI that he anticipates will deliver strong long-term returns.
Despite the negative stock reaction, the company's fundamentals showed strength. Amazon Web Services (AWS) reported a healthy 24% revenue growth to $35.6 billion, its fastest in 13 quarters, beating expectations. This spending is also being partly offset by cost-cutting elsewhere, with Amazon shutting its Fresh and Go grocery outlets and trimming its corporate workforce by roughly 30,000 since October.
Analysts remain divided. Some compare the current environment to the dot-com bubble, but note that relief could come from potential interest-rate cuts by the Federal Reserve, a stark contrast to the rate hikes that burst the bubble in 2000. Dan Ives of Wedbush Securities characterised the sell-off as an "Armageddon scenario for the sector that is far from reality."
Anthropic Triggers a 'SaaSpocalypse'
The market's anxiety was compounded by a dramatic sell-off in the software-as-a-service (SaaS) sector, ignited by product unveilings from AI firm Anthropic. The launch of its Claude Opus 4.6 model, which features 'agent teams' capable of automating complex workflows, sent a wave of fear through the industry. The iShares Expanded Tech-Software Sector ETF is now poised for its biggest weekly drop since 2008.
Investors reacted swiftly, erasing roughly $285 billion (£225 billion) in market value from a Goldman Sachs basket of US software stocks in a single day. The core fear is that autonomous AI agents could cannibalise the lucrative 'per-seat' subscription models that have long been the bedrock of the software industry.
This was reflected in sharp declines for several established firms:
- Thomson Reuters fell approximately 16%.
- LegalZoom dropped around 19%.
- Intuit and Salesforce also saw significant slides.
A Reality Check on AI Agents
Despite the market panic, the narrative that AI agents will render the entire software industry obsolete is premature. Current large language models still suffer from significant limitations, including hallucinations and major security risks. Crucially, these AI agents do not replace enterprise software; they operate on top of it. An agent designed to manage customer relations still requires a CRM system to interact with. In the medium term, this could increase the value of companies that provide high-quality, authoritative data and robust APIs.
The AI Advertising Spat
The rivalry in the AI space is also intensifying on the public stage. Anthropic released a Super Bowl advertising campaign this week that took a direct swipe at competitor OpenAI's decision to test ads on its ChatGPT platform. While OpenAI CEO Sam Altman acknowledged the campaign was "funny," he also labelled it "deceptive." This public sparring underscores the high stakes as companies vie for dominance.
AI Ripple Effects Create Smartphone Supply Crisis
The AI infrastructure boom is creating significant collateral damage in other parts of the technology sector. The immense demand for memory chips from AI data centres is causing a supply shortage that is now choking smartphone chip designers like Qualcomm and Arm.
Both companies saw their share prices plunge recently after issuing disappointing forecasts. The core issue is that as data centres hoard critical high-bandwidth memory, consumer phone manufacturers cannot secure the necessary components at reasonable prices, forcing them to slash production forecasts. Ironically, while demand for premium smartphones remains healthy, these supply chain bottlenecks prevent manufacturers from capitalising on it. This highlights how the AI arms race is creating a hierarchy of winners and losers even within the tech industry.
Broader Market Weakness and Economic Strain
The turmoil in the tech sector, which has put the Nasdaq Composite on track for its worst week since April, occurred alongside a broader risk-off move. The S&P 500 has been pulled into negative territory for 2026, with worrying signals emerging from crypto, labour, and bond markets.
Crypto Fails its 'Safe Haven' Test
The cryptocurrency market has decisively failed its 'safe haven' test, with Bitcoin plunging nearly 30% this week and narrowly avoiding a drop below the critical $60,000 level. This marks its steepest weekly fall since the collapse of FTX in November 2022 and takes the digital asset to its weakest price since October 2024.
Analysts attribute the severity of the drop to extremely thin market liquidity. The next critical support level is seen around the 200-day moving average, between $58,000 and $60,000. This latest crash exposes a deeper malaise. Many analysts believe a "crypto winter" began in January 2025, but its full impact was masked by an estimated $75 billion in ETF flows. Unsupported altcoins such as Cardano (ADA) and Avalanche (AVAX) have collapsed by over 70%, revealing a brutal underlying bear market for retail investors.
Labour Market and Bond Yields Flash Warnings
Adding to the negative sentiment were clear signs of a weakening labour market. Initial unemployment claims rose by 22,000 to 231,000 for the week ending 31 January, surpassing forecasts. This data reinforces the concerning trend seen earlier in the month, when U.S. firms announced the highest number of job cuts for January since 2009.
Meanwhile, the U.S. Treasury 'yield curve' has steepened to its highest level since 2022. This widening gap between short-term (2-year) and long-term (10-year) bond yields often signals investor concern about future inflation and government debt levels.
Stellantis Stumbles on Overhaul Costs
Underscoring the pressure on established industries, automaker Stellantis saw its U.S.-listed shares fall by more than 25% after announcing it expects to take a $26 billion hit from a major business overhaul. The parent company of Chrysler and Dodge was already having a difficult year, with shares down over 12% year-to-date, highlighting the immense financial strain on legacy companies navigating technological transitions.
Consumer Sector Under Strain Amid 'Subscription Hangover'
The economic pressure is not confined to the tech world, with the consumer discretionary sector showing clear signs of fatigue. The fitness industry is grappling with a 'subscription hangover' as consumers abandon pricey plans for free workouts and low-commitment options. This was underscored by at-home fitness firm Peloton, whose shares plunged more than 25% after reporting weak quarterly earnings and demand.
This has created a polarised market where budget chains and luxury clubs thrive, while mid-tier offerings are hollowed out. The strain is visible elsewhere, with cosmetics giant Estée Lauder tumbling more than 19% after warning investors of a $100 million hit to profitability from tariffs.
This trend reflects a broader value reset among consumers. They are no longer willing to pay for brand names alone and will only commit to subscriptions that offer a demonstrably better experience than free alternatives. This shift poses a significant challenge for companies built on recurring revenue models in the discretionary space.
Tesla Pivots from Cars to Humanoid Robots
In a distinct but related development, Tesla announced a major strategic pivot toward robotics. The company plans to cease production of its flagship Model S and Model X vehicles at its Fremont factory to repurpose the facility for its humanoid robot, Optimus. The ambitious goal is to produce one million Optimus units annually.
This move places Tesla in direct competition with firms like Hyundai, which plans to deploy Boston Dynamics' 'Atlas' robot in its factories. The shift highlights the move toward 'Embodied AI'—giving artificial intelligence a physical form. This emerging sector could represent a $5 trillion annual market by 2050. Investors are now looking beyond the robots themselves to the entire supply chain.
Broader EV Market Remains Resilient
Tesla's strategic shift occurs even as the broader electric vehicle market demonstrates surprising resilience. Global EV sales climbed 20% in 2025 to reach 20.7 million units, defying narratives of a major slowdown. While North American sales slipped 4% due to policy changes, Europe saw a 33% surge in demand. Crucially, the charging infrastructure required to support this growth continues to expand rapidly.
New Battlegrounds Emerge Amid Market Volatility
The current market turmoil is not just creating risks, but also highlighting new areas of intense corporate competition and shifting investor focus.
IPO Market Navigates Cautious Sentiment
The volatile backdrop is impacting the market for new listings. Liftoff Mobile, an AI-powered advertising platform, postponed its initial public offering, citing unfavourable market conditions. However, the pipeline is not frozen. Bob’s Discount Furniture proceeded with its debut on the New York Stock Exchange, with shares finishing near flat, valuing the company at $2.22 billion. This suggests investor appetite is discerning rather than absent, with a preference for profitable companies over speculative ventures.
Weight-Loss Drug Market Heats Up
A fierce battle is escalating in the lucrative weight-loss drug market. Telehealth firm Hims & Hers has challenged industry giant Novo Nordisk by launching a lower-priced pill with the same active ingredient as the blockbuster drug Wegovy. Hims is pricing its generic version at $99 per month, significantly undercutting Novo's $149 price.
Novo Nordisk has responded aggressively, labelling the move "illegal mass compounding" and threatening legal action. The conflict highlights the immense commercial pressures in a market where Novo faces increased competition from Eli Lilly's Zepbound and is already forecasting a sales decline for 2026.
Trump Enters the Fray with Drug Pricing Platform
Adding a new dimension to the pricing debate, former President Donald Trump launched his TrumpRx platform, a direct-to-consumer website aimed at lowering prescription drug costs. The site directs users to discounted purchasing options. While positioned as a tool to save consumers money, experts question whether the platform alone can solve the industry's broader affordability problems, which see U.S. prices at two to three times the average of other developed nations.
NOTE: This content is for informational and educational purposes only and does not constitute financial advice. Always do your own research. Not financial advice (NFA).